Immucell Corp (ICCC) Reports Q3 Loss of $0.12
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- BofA Securities Reiterates Buy Rating on Apple (AAPL)
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023
November 13, 2023 4:05 PM ESTPORTLAND, Maine, Nov. 13, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (ImmuCell or the Company), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, today announced its unaudited financial results for the quarter ended September 30, 2023.
Managements Discussion:
Our unaudited, preliminary product sales for the third quarter of 2023 were first reported on October 5, 2023, commented Michael F. Brigham, President and CEO of ImmuCell. We have no changes to those figures.
The production slowdown that was necessary to remediate several contamination events materially... More
